
Helius Medical Technologies HSDT
$ 1.93
-0.52%
Quarterly report 2025-Q3
added 11-18-2025
Helius Medical Technologies DSO Ratio 2011-2026 | HSDT
Annual DSO Ratio Helius Medical Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.3 | 31.8 | 48.9 | 127 | 140 | 210 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 210 | 31.8 | 102 |
Quarterly DSO Ratio Helius Medical Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 131 | 42.6 | 56.1 | - | 75.9 | 27.6 | 33.7 | - | 6.98 | 26.4 | 30.3 | - | 31 | 64.3 | 66.8 | - | 51.5 | 50.8 | 62.6 | - | 128 | 37 | 26.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 131 | 6.98 | 52.7 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 291.94 | -1.36 % | $ 8.24 B | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 38.89 | -1.49 % | $ 5.8 K | ||
|
Align Technology
ALGN
|
86.7 | $ 186.76 | 0.12 % | $ 14 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.39 | -2.09 % | $ 1.67 B | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.62 | 4.78 % | $ 38.6 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.59 | 1.85 % | $ 134 M | ||
|
LENSAR
LNSR
|
38.9 | $ 6.01 | -3.84 % | $ 71.9 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 64.29 | -0.5 % | $ 95.2 B | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 10.45 | -0.14 % | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
137 | $ 25.88 | 0.66 % | $ 219 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Sintx Technologies
SINT
|
67 | $ 2.8 | 2.19 % | $ 7.77 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Stryker Corporation
SYK
|
204 | $ 339.44 | -0.53 % | $ 130 B | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 17.42 | -2.44 % | $ 409 M | ||
|
Globus Medical
GMED
|
76.8 | $ 93.7 | -0.9 % | $ 12.7 B | ||
|
Tactile Systems Technology
TCMD
|
49.2 | $ 25.31 | -0.16 % | $ 579 M | ||
|
TELA Bio
TELA
|
46.5 | $ 0.67 | 3.04 % | $ 31.5 M | ||
|
Butterfly Network
BFLY
|
76.1 | $ 5.05 | 3.81 % | $ 1.07 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
TransMedics Group
TMDX
|
54.9 | $ 111.72 | -3.78 % | $ 3.8 B | ||
|
Tandem Diabetes Care
TNDM
|
176 | $ 20.43 | -1.11 % | $ 1.39 B | ||
|
Inogen
INGN
|
35.8 | $ 6.19 | -0.16 % | $ 165 M | ||
|
IRIDEX Corporation
IRIX
|
47.5 | $ 1.03 | -0.96 % | $ 17.4 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
48.5 | $ 10.79 | -1.82 % | $ 387 M | ||
|
Inspire Medical Systems
INSP
|
42.6 | $ 56.65 | 0.02 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 39.15 | -0.74 % | $ 1.22 B |